Mangalam Organics profit and loss

Latest FY26

Revenue: ₹623cr+17.5% on FY25
EBITDA: ₹87.8cr+49.9% on FY25
Net profit: ₹25.8cr+104.5% on FY25
EPS: ₹29.64+103.0% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	655	623	530	494	493	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.8	4.7	0.3	0.8	0.3
	656	627	530	494	493
	407	365	312	259	409
	7.8	7.9	6.9	6.4	6.5
	−62.4	−45.2	−45.9	37.4	−72.6
	52.2	49.9	41.5	39.1	34.7
	29.9	28.2	21.5	15.6	13.8
	28.5	27.6	20.8	19.8	17.5
	162	157	156	113	117
	625	591	514	490	527
	88.4	87.8	58.6	38.7	−2.8
	59.9	60.2	37.8	18.8	−20.3
Profit
	30.8	36.8	16.6	4.0	−33.8
	−3.5	−3.5	0.0	0.0	0.0
	27.3	33.3	16.6	4.0	−33.8
	1.1	2.0	0.5	0.0	1.5
	5.4	5.6	3.6	1.1	−8.0
	6.5	7.5	4.0	1.1	−6.5
	0.0	0.0	0.0	1.4	0.0
	20.8	25.8	12.6	4.3	−27.2
	20.8	25.8	12.6	4.3	−27.2
	−0.4	−0.4	−0.1	−0.1	0.1
	20.4	25.4	12.5	4.2	−27.1
	—	25.8	12.6	4.3	−27.2
Per share
	₹23.85	₹29.64	₹14.60	₹4.92	−₹31.63
	₹23.85	₹29.64	₹14.60	₹4.92	−₹31.63
Other comprehensive income — detail
	—	−0.4	−0.1	—	—
	—	0.4	0.0	—	—
	—	0.0	0.1	—	—
	—	25.8	12.6	4.3	−27.2
Per share — as-filed variants
	₹23.85	₹29.64	₹14.60	₹4.92	−₹31.63
	₹23.85	₹29.64	₹14.60	₹4.92	−₹31.63
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	303	295	257	191	149
	46.3%	47.3%	48.4%	38.7%	30.3%
Adjusted (ex-exceptional items) — derived
	30.8	36.8	16.6	4.0	−33.8
	−3.5	−3.5	0.0	0.0	0.0
	23.5	28.5	12.6	4.3	−27.2
	₹26.91	₹32.76	₹14.60	₹4.92	−₹31.63

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MANORG₹436.40

Mangalam Organics Limited

· Chemicals

Annual Quarterly₹ CrorePeersPLASTIBLEN LORDSCHLO PRIMO CHEMFAB HPAL DYNPRO KRONOX JAYAGROGNMcap ₹374 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	492.5	493.5	530.0	622.6	655.1
Other Income	0.3	0.8	0.3	4.7	0.8
Total Income	492.9	494.3	530.3	627.3	655.9
Expenses
+ Cost of Materials Consumed	409.4	258.9	312.5	365.3	406.6
+ Purchases of Stock-in-Trade	6.5	6.4	6.9	7.9	7.8
+ Changes in Inventories	-72.6	37.4	-45.9	-45.2	-62.4
+ Employee Benefit Expense	34.7	39.1	41.5	49.9	52.2
+ Finance Costs	13.8	15.6	21.5	28.2	29.9
+ Depreciation & Amortisation	17.5	19.8	20.8	27.6	28.5
+ Other Expenses	117.4	113.1	156.4	156.8	162.5
Total Expenses	526.6	490.3	513.7	590.5	625.1
EBITDA	-2.8	38.7	58.6	87.8	88.4
EBIT	-20.3	18.8	37.8	60.2	59.9
Profit
PBT before Exceptional Items	-33.8	4.0	16.6	36.8	30.8
+ Exceptional Items	0.0	0.0	0.0	-3.5	-3.5
Pretax Income	-33.8	4.0	16.6	33.3	27.3
+ Current Tax	1.5	0.0	0.5	2.0	1.1
+ Deferred Tax	-8.0	1.1	3.6	5.6	5.4
Tax Expense	-6.5	1.1	4.0	7.5	6.5
+ Net Movement in Regulatory Deferral Balances	0.0	1.4	0.0	0.0	0.0
Net Income	-27.2	4.3	12.6	25.8	20.8
+ Net Income — Continuing Ops	-27.2	4.3	12.6	25.8	20.8
+ Other Comprehensive Income	0.1	-0.1	-0.1	-0.4	-0.4
Total Comprehensive Income	-27.1	4.2	12.5	25.4	20.4
Net Income to Common	-27.2	4.3	12.6	25.8	—
Per Share
Basic EPS	-31.63	4.92	14.60	29.64	23.85
Diluted EPS	-31.63	4.92	14.60	29.64	23.85
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-0.1	-0.4	—
+ Tax on Items NOT to be Reclassified	—	—	0.0	0.4	—
+ Tax on Items to be Reclassified	—	—	0.1	0.0	—
Comprehensive Income — Owners of Parent	-27.2	4.3	12.6	25.8	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	-31.63	4.92	14.60	29.64	23.85
Diluted EPS — Continuing Operations	-31.63	4.92	14.60	29.64	23.85
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	149.3	190.8	256.5	294.5	303.1
Gross Margin %	30.31	38.67	48.40	47.31	46.27
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	-33.8	4.0	16.6	36.8	30.8
− Exceptional Items (reconciliation)	0.0	0.0	0.0	-3.5	-3.5
Net Income Adj (tax-effected)	-27.2	4.3	12.6	28.5	23.5
EPS Adj	-31.63	4.92	14.60	32.76	26.91
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	8.6	8.6	8.6	8.6	8.6

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.